0001437749-17-018054.txt : 20171101 0001437749-17-018054.hdr.sgml : 20171101 20171101171426 ACCESSION NUMBER: 0001437749-17-018054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171030 FILED AS OF DATE: 20171101 DATE AS OF CHANGE: 20171101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SARGEN GREGORY CENTRAL INDEX KEY: 0001227835 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10638 FILM NUMBER: 171169874 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CAMBREX CORP CENTRAL INDEX KEY: 0000820081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222476135 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MEADOWLANDS PLZ CITY: E RUTHERFORD STATE: NJ ZIP: 07073 BUSINESS PHONE: 2018043000 MAIL ADDRESS: STREET 1: ONE MEADOWLANDS PLAZA CITY: E. RUTHERFORD STATE: NJ ZIP: 07073 4 1 rdgdoc.xml FORM 4 X0306 4 2017-10-30 0000820081 CAMBREX CORP CBM 0001227835 SARGEN GREGORY ONE MEADOWLANDS PLAZA EAST RUTHERFORD NJ 07073 1 EVP, Corporate Development Stock Option (right to buy) 45.635 2017-10-30 4 A 0 25000 0 A 2024-10-30 Common Stock 25000 25000 D The option representing a right to purchase a total of 25,000 shares becomes exercisable in four equal installments beginning October 30, 2018, which is the first anniversary of the date on which the option was granted. /s/ Danielle Mann for Gregory P. Sargen by POA 2017-11-01